Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease - the BEST Multi-centre Randomised Controlled Trial

NCT05622500 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05622500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05622500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease - the BEST Multi-centre Randomised Controlled Trial
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Terminated
Start date
September 3, 2022
Completion date
April 8, 2025
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic venous insufficiency, chronic venous thrombosis, iliac vein obstruction, iliac vein stenosis, post thrombotic syndrome